idarubicin has been researched along with lewis x antigen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avvisati, G; Breccia, M; Carmosino, I; Cimino, G; De Propris, MS; Gentilini, F; Guarini, A; Latagliata, R; Lo-Coco, F; Mandelli, F; Petti, MC | 1 |
1 trial(s) available for idarubicin and lewis x antigen
Article | Year |
---|---|
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; CD2 Antigens; Female; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocyte Count; Lewis X Antigen; Male; Middle Aged; Mutation; Predictive Value of Tests; Risk Factors; Tandem Repeat Sequences; Thrombosis; Tretinoin | 2007 |